‘Picture This’ forums bring diabetes management awareness to public
PRINCETON, N.J. A few days after it released a report on how awareness and education play an integral role in the prevention, detection and treatment of diabetes, Novo Nordisk is bringing it to the public.
The drug maker said Friday that, through its collaboration with the Entertainment Industries Council, it will host "Picture This" forums, which include an open discussion among diabetes stakeholders and the media to identify top diabetes communication challenges, explore strategies to address those priorities and strengthen community understanding about diabetes through news media and community affairs programs.
The forums will be held in Philadelphia on Oct. 22 and Seattle on Nov. 18.
"Novo Nordisk is proud to join EIC, the media and community leaders in Seattle and Philadelphia to explore ways to improve how diabetes is communicated about and understood by local citizens," said Tony Deluzio, senior medical director at Novo Nordisk. "As the prevalence of diabetes continues to be on the rise, bringing together those on the front line of diabetes care will open the potential to reduce the stigma associated with diabetes and empower those affected by the disease to lead full and productive lives."
Mylan gets nod for additional strengths of generic Mirapex
PITTSBURGH The Food and Drug Administration has approved a Mylan generic drug for Parkinson’s disease, Mylan said Thursday.
The drug maker announced the approval of pramipexole dihydrochloride tablets in the 0.125-mg, 0.25-mg, 0.5-mg, 1-mg and 1.5-mg strengths. The drug is a generic version of Boehringer Ingelheim’s Mirapex.
Various versions of the drug had sales of $536 million during the 12-month period ended in June, according to IMS Health. Mylan has had approval of a 0.75-mg formulation of the drug since April, and plans to immediately begin shipping the newly approved strengths.
Diplomat takes employees back to school
SWARTZ CREEK, Mich. A specialty pharmacy provider is creating an online tool to train and educate new and existing employees.
Diplomat Specialty Pharmacy announced Wednesday the launch of Diplomat University, saying it would use the Web-based tool as a platform for expanding into clinical trials and outcomes research. The company hired Ferris State University pharmacy professor Jennifer Hagerman to develop and implement programs for the project.
“I started my career in pharmacy as a technician at Diplomat and am thrilled to return as the director of education,” Hagerman said. “I look forward to helping implement educational programs for new and current staff, based on their role and specialty area, so they can continue to provide the best care for our patients.”